Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin.

Francisco Galeano-ValleG Pérez-RusP Demelo-RodríguezL Ordieres-OrtegaL Ortega-MoránA J Muñoz-MartínS Medina-MolinaL A Alvarez-Sala-WaltherJ Del-Toro-Cervera

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

In patients with venous thromboembolism treated with bemiparin, anti-Xa levels were not influenced by the presence of cancer.

Keyphrases

venous thromboembolism
direct oral anticoagulants
papillary thyroid
squamous cell
newly diagnosed
young adults